Bernd Lamprecht

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Luis Paz‐Ares, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet · 2019 · 2.1K citations

Platinum–etoposide Versus Platinum–etoposide, Medicine, Pharmacology +6

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

Jonathan W. Goldman, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet Oncology · 2020 · 662 citations · Full text

Platinum–etoposide Versus Platinum–etoposide, Medicine, Pathology +6

COPD in Never Smokers

Bernd Lamprecht, Mary Ann McBurnie, William M. Vollmer et al. · CHEST Journal · 2010 · 509 citations · Full text

Determinants of Underdiagnosis of COPD in National and International Surveys

Bernd Lamprecht, Joan B. Soriano, Michael Studnicka et al. · CHEST Journal · 2015 · 428 citations

Epidemiology, Pulmonary Care, International Surveys +6

Electromagnetic Navigation Bronchoscopy for Peripheral Pulmonary Lesions: One-Year Results of the Prospective, Multicenter NAVIGATE Study

Erik Folch, Michael A. Pritchett, Michael Nead et al. · Journal of Thoracic Oncology · 2018 · 393 citations · Full text